Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Rupatadine Study in Chronic Urticaria
jRCTs031190058Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of rupatadine in chronic urticaria (CU) (2 arms), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Time to skin eruption disappearance. Started Aug 2019; status: completed.
02
Drugs
rupatadine
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on jRCTs031190058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190058.